Mostrando resultados 1 a 20 de 126
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 18-dic-2019 | A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors | Pérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu CSIC ORCID ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Alberto | artículo |
| openAccess |  | 2014 | Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis | Ocaña, Alberto; Cuenca-López, María D.; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan | artículo |
| closedAccess |  | 2012 | Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer | Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Re-Louhau, M. F. CSIC; Seoane, Samuel CSIC ORCID; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 30-ago-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| closedAccess |  | 2020 | Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms | Ríos-Luci, Carla; Díaz-Rodríguez, Elena CSIC ORCID CVN; Gandullo-Sánchez, Lucía CSIC ORCID; Díaz-Gil, Laura CSIC; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 23-mar-2022 | Additional file 1 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
| openAccess | | 23-mar-2022 | Additional file 2 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
| openAccess | | 23-mar-2022 | Additional file 3 of Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer [Dataset] | Montero, Juan Carlos CSIC ORCID; Calvo-Jiménez, Elisa; Carmen, Sofía del; Abad, María del Mar; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | dataset |
| openAccess |  | oct-2020 | Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine | Fuentes-Antrás, Jesús; Guevara-Hoyer, Kissy; Baliu-Piqué, Mariona; García-Saenz, José Ángel; Pérez-Segura, Pedro; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo de revisión |
| closedAccess |  | 17-may-2018 | Alteraciones transcripcionales en la vía de la ubiquitina-proteasoma (UPP) de células HER2+ resistentes a trastuzumab | Orive-Ramos, Ana CSIC; Pérez-Peña, Javier; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | comunicación de congreso |
| openAccess |  | 2021 | Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma | García-Alonso, Sara; Romero-Pérez, Inés; Gandullo-Sánchez, Lucía CSIC ORCID; Chinchilla, Luis; Ocaña, Alberto; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2020 | An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso-Moreno, Carlos | artículo |
| openAccess |  | 21-ago-2020 | Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment | Juan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto; Alonso, Carlos CSIC | artículo |
| openAccess |  | 2015 | Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer | Cuenca-López, María D.; Serrano-Heras, Gemma CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2022 | Antitumoral activity of a CDK9 PROTAC compound in HER2-Positive breast cancer | Noblejas-López, María del Mar; Gandullo-Sánchez, Lucía CSIC ORCID; Galán-Moya, Eva María; López-Rosa, Raquel; Tebar-García, David; Nieto-Jiménez, Cristina; Gómez-Juárez, Mónica; Burgos, Miguel; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2015 | Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2 | Pandiella, Atanasio CSIC ORCID CVN ; Morís, Francisco; Ocaña, Alberto; Núñez, Luz-Elena; Montero, Juan Carlos CSIC ORCID | artículo |
| openAccess |  | 2017 | BET inhibitors as novel therapeutic agents in breast cancer | Ocaña, Alberto; Nieto-Jiménez, Cristina; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2014 | Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors | Ocaña, Alberto; Freedman, Orit; Amir, Eitan; Seruga, Bostjan; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2016 | Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node | Seoane, Samuel CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2020 | Breast Cancer Heterogeneity and Response to Novel Therapeutics | Baliu-Piqué, Mariona; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
